Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pharmacotherapy in pregnancy].

W E Paulus1

  • 1Beratungszentrum für Reproduktionstoxikologie, Roggenburg.

Therapeutische Umschau. Revue Therapeutique
|November 5, 1999
PubMed
Summary

The thalidomide tragedy highlights the risks of medications during pregnancy. Careful consideration of drug safety, dose, and timing is crucial to prevent birth defects and ensure healthy fetal development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Otorhinolaryngological diseases in pregnancy-which drugs are approved?]

HNO·2022
Same author

[Affective disorders during pregnancy : Therapy with antidepressants and mood stabilizers].

Der Nervenarzt·2016
Same author

[Psychopharmacotherapy during pregnancy : Which antipsychotics, tranquilizers and hypnotics are suitable?].

Der Nervenarzt·2016
Same author

Influence of acupuncture on idiopathic male infertility in assisted reproductive technology.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban·2003
Same author

Prenatal diagnosis of an aortico-left ventricular tunnel.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2000
Same author

Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2000

Area of Science:

  • Teratology
  • Pharmaceutics
  • Obstetrics

Context:

  • The historical impact of thalidomide (1958-1961) on approximately 10,000 children with severe limb defects.
  • Widespread, yet often irrational, caution surrounding pharmaceutical use during pregnancy.
  • High prevalence (15-50%) of medication use in early pregnancy, frequently before awareness of gestation.

Purpose:

  • To review the risks of pharmaceutical agents during pregnancy, particularly during the first trimester's organogenesis.
  • To highlight known teratogenic drugs (e.g., thalidomide, warfarin, isotretinoin, anticonvulsants) and potential embryotoxic/fetotoxic agents.
  • To address the balance between maternal health needs and fetal safety, and the lack of statistically valid studies for many drugs.

Summary:

  • Pharmaceuticals taken during early pregnancy pose significant risks, including severe birth defects, as exemplified by thalidomide.
  • Numerous drugs, including anticoagulants, retinoids, antifolates, and anticonvulsants, are identified as potentially harmful.
  • Drug effects are dependent on dosage and timing of exposure, necessitating cautious prescribing and patient information.

Impact:

  • Informed decision-making for patients and healthcare providers regarding medication use in pregnancy.
  • Reduced incidence of drug-induced fetal malformations and adverse pregnancy outcomes.
  • Advocacy for specialized information centers in reproductive toxicology to manage exposure risks.

Related Experiment Videos